Magnus Stougaard

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Signe Neldeborg, Johannes Frasez Soerensen, Charlotte Thornild Møller, Marie Bill, Zongliang Gao, Rasmus O Bak, Kasper Holm, Boe Sandahl Sørensen, Mette Nygaard, Yonglun Luo, Peter Hokland, Magnus Stougaard, Maja Ludvigsen, Christian Kanstrup Holm
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. Leukemia (2023)
Jacob Kinggaard Lilja-Fischer, Morten Horsholt Kristensen, Pernille Lassen, Torben Steiniche, Trine Tramm, Magnus Stougaard, Christian Maare, Jorgen Johansen, Hanne Primdahl, Claus Andrup Kristensen, Maria Andersen, Jesper Grau Eriksen, Jens Overgaard
HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study. Acta oncologica (Stockholm, Sweden) (2023)
Ea Maria Tønning Tønnesen, Magnus Stougaard, Peter Meldgaard, Johanne Lade-Keller
Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy. Journal of clinical pathology (2022)